Fludarabine
Vaginal Cancer
Christian HinrichsSmall moleculePhase 2Active
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
9 Active assets in the Vaginal Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Christian Hinrichs | Phase 2 | BB |
Octreotide Pamoate Alliance for Clinical Trials in Oncology | Phase 3 | B |
e7 tcr-t cells Christian Hinrichs | Phase 2 | B |
Durvalumab M.D. Anderson Cancer Center | Phase 2 | B |
FONDAPARINUX Masonic Cancer Center, University of Minnesota | Phase 2 | B |
View all 27 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →